Impact of myelodysplasia‐related and additional gene mutations in intensively treated patients with NPM1‐mutated AML

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1DNMT3A R882 Mutations Predict a Poor Prognosis in AML2016 · 48 citations
2. 2The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes2009 · 4,422 citations
3. 3New FDR bounds for discrete and heterogeneous tests2018 · 31 citations
4. 4The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data2010 · 30,107 citations
5. 5Multilineage dysplasia has no impact on biologic, clinicopathologic, and prognostic features of AML with mutated nucleophosmin (NPM1)2010 · 121 citations